Cargando…

Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance

Multidrug resistance is still a major obstacle to cancer treatment. The most studies are to inhibit the activity of the drug transporter P-glycoprotein (P-gp), but the effect is not ideal. Herein, a nanosystem was built based on cascade catalytic consumption of cholesterol. Cholesterol oxidase (natu...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Bin, Zheng, Mei, Ma, Huizhen, Huang, Jingshu, Jiao, Qingqing, Bai, Yimeng, Zhao, Mengmeng, Zhou, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063293/
https://www.ncbi.nlm.nih.gov/pubmed/35501796
http://dx.doi.org/10.1186/s12951-022-01406-9
_version_ 1784699134475763712
author Du, Bin
Zheng, Mei
Ma, Huizhen
Huang, Jingshu
Jiao, Qingqing
Bai, Yimeng
Zhao, Mengmeng
Zhou, Jie
author_facet Du, Bin
Zheng, Mei
Ma, Huizhen
Huang, Jingshu
Jiao, Qingqing
Bai, Yimeng
Zhao, Mengmeng
Zhou, Jie
author_sort Du, Bin
collection PubMed
description Multidrug resistance is still a major obstacle to cancer treatment. The most studies are to inhibit the activity of the drug transporter P-glycoprotein (P-gp), but the effect is not ideal. Herein, a nanosystem was built based on cascade catalytic consumption of cholesterol. Cholesterol oxidase (natural enzyme, COD) was immobilized on the carrier (NH(2)-MIL-88B, MOF) through amide reaction, COD catalyzed the consumption of cholesterol, the reaction product H(2)O(2) was further produced by the MOF with its peroxidase-like activity to produce hydroxyl radicals (•OH) with killing effect. Due to the high expression of CD44 receptor on the surface of tumor cells, we encapsulated chondroitin sulfate gel shell (CS-shell) with CD44 targeting and apoptosis promoting effect on the surface of DOX@MOF-COD nanoparticles, which can accurately and efficiently deliver the drugs to the tumor site and improve the effect of reversing drug resistance. Taking drug-resistant cell membrane as "breakthrough", this paper will provide a new idea for reversing multidrug resistance of tumor. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-022-01406-9.
format Online
Article
Text
id pubmed-9063293
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-90632932022-05-04 Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance Du, Bin Zheng, Mei Ma, Huizhen Huang, Jingshu Jiao, Qingqing Bai, Yimeng Zhao, Mengmeng Zhou, Jie J Nanobiotechnology Research Multidrug resistance is still a major obstacle to cancer treatment. The most studies are to inhibit the activity of the drug transporter P-glycoprotein (P-gp), but the effect is not ideal. Herein, a nanosystem was built based on cascade catalytic consumption of cholesterol. Cholesterol oxidase (natural enzyme, COD) was immobilized on the carrier (NH(2)-MIL-88B, MOF) through amide reaction, COD catalyzed the consumption of cholesterol, the reaction product H(2)O(2) was further produced by the MOF with its peroxidase-like activity to produce hydroxyl radicals (•OH) with killing effect. Due to the high expression of CD44 receptor on the surface of tumor cells, we encapsulated chondroitin sulfate gel shell (CS-shell) with CD44 targeting and apoptosis promoting effect on the surface of DOX@MOF-COD nanoparticles, which can accurately and efficiently deliver the drugs to the tumor site and improve the effect of reversing drug resistance. Taking drug-resistant cell membrane as "breakthrough", this paper will provide a new idea for reversing multidrug resistance of tumor. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12951-022-01406-9. BioMed Central 2022-05-02 /pmc/articles/PMC9063293/ /pubmed/35501796 http://dx.doi.org/10.1186/s12951-022-01406-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Du, Bin
Zheng, Mei
Ma, Huizhen
Huang, Jingshu
Jiao, Qingqing
Bai, Yimeng
Zhao, Mengmeng
Zhou, Jie
Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance
title Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance
title_full Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance
title_fullStr Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance
title_full_unstemmed Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance
title_short Nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance
title_sort nanozyme-natural enzymes cascade catalyze cholesterol consumption and reverse cancer multidrug resistance
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9063293/
https://www.ncbi.nlm.nih.gov/pubmed/35501796
http://dx.doi.org/10.1186/s12951-022-01406-9
work_keys_str_mv AT dubin nanozymenaturalenzymescascadecatalyzecholesterolconsumptionandreversecancermultidrugresistance
AT zhengmei nanozymenaturalenzymescascadecatalyzecholesterolconsumptionandreversecancermultidrugresistance
AT mahuizhen nanozymenaturalenzymescascadecatalyzecholesterolconsumptionandreversecancermultidrugresistance
AT huangjingshu nanozymenaturalenzymescascadecatalyzecholesterolconsumptionandreversecancermultidrugresistance
AT jiaoqingqing nanozymenaturalenzymescascadecatalyzecholesterolconsumptionandreversecancermultidrugresistance
AT baiyimeng nanozymenaturalenzymescascadecatalyzecholesterolconsumptionandreversecancermultidrugresistance
AT zhaomengmeng nanozymenaturalenzymescascadecatalyzecholesterolconsumptionandreversecancermultidrugresistance
AT zhoujie nanozymenaturalenzymescascadecatalyzecholesterolconsumptionandreversecancermultidrugresistance